CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 130 enrolled
Drug / intervention
Vaginal Misoprostol +1 moredrug
Likely dose
Vaginal Misoprostol 25 µgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01634854
NCT01634854N/ACompleted
CompareCT.gov

Randomized Comparison of Vaginal Misoprostol and Intravenous Oxytocin for Labor Induction in Multiparous Women

Vanderbilt University Medical Center·interventional·Posted Jul 6, 2012·Updated Dec 19, 2017

In Brief

A clinical study evaluating Vaginal Misoprostol and Intravenous Oxytocin for Induction of Labor in Multiparous Women. Completed, enrolled 130 participants.

Detailed Summary

This study will compare the effectiveness of vaginal misoprostol (Cytotec) and intravenous oxytocin (Pitocin) in multiparous women who present at term for labor induction.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInduction of Labor in Multiparous Women
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJul 6, 2012
Enrollment StartJul 1, 2012
Primary CompletionMay 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 14.0 years ago

Interventions

Vaginal Misoprostoldrug

Dosage: 25 µg every 4 hours up to a maximum of 4 doses until cervical change is consistent with a diagnosis of active labor Route of administration: Intravaginal

Intravenous Oxytocindrug

Dosage: 2 miu per minute increased in increments of 1-2 miu per minute every 30 minutes to establish an effective contraction pattern. Route of administration: intravenous